The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF.
J Biol Chem, 2008/12/26;283(52):36542-52.
Beyer S[1], Kristensen MM, Jensen KS, Johansen JV, Staller P
Affiliations
PMID: 18984585DOI: 10.1074/jbc.M804578200
Abstract
Posttranslational histone modifications serve to store epigenetic information and control both nucleosome assembly and recruitment of non-histone proteins. Histone methylation occurs on arginine and lysine residues and is involved in the regulation of gene transcription. A dynamic control of these modifications is exerted by histone methyltransferases and the recently discovered histone demethylases. Here we show that the hypoxia-inducible factor HIF-1alpha binds to specific recognition sites in the genes encoding the jumonji family histone demethylases JMJD1A and JMJD2B and induces their expression. Accordingly, hypoxic cells express elevated levels of JMJD1A and JMJD2B mRNA and protein. Furthermore, we find increased expression of JMJD1A and JMJD2B in renal cancer cells that have lost the von Hippel Lindau tumor suppressor protein VHL and therefore display a deregulated expression of hypoxia-inducible factor. Studies on ectopically expressed JMJD1A and JMJD2B indicate that both proteins retain their histone lysine demethylase activity in hypoxia and thereby might impact the hypoxic gene expression program.
MeSH terms
Arginine; Base Sequence; Gene Expression Regulation; HeLa Cells; Histone Deacetylases; Histones; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Jumonji Domain-Containing Histone Demethylases; Kidney; Lysine; Microscopy, Fluorescence; Molecular Sequence Data; Oxidoreductases, N-Demethylating; Transcription Factors
More resources
Full text:
Europe PubMed Central; PubMed Central
EndNote: Download